Anti-NMDAR1 antibody impairs dendritic branching in immature cultured neurons
Jazyk angličtina Země Polsko Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
GAUK 365121
Charles University - Czech Republic
PubMed
39434510
DOI
10.32725/jab.2024.019
Knihovny.cz E-zdroje
- Klíčová slova
- Anti-NMDAR encephalitis, BDNF, Dendritic branching, Neuronal development, Synaptic proteins,
- MeSH
- dendrity * účinky léků metabolismus MeSH
- krysa rodu Rattus MeSH
- kultivované buňky MeSH
- membránové proteiny metabolismus imunologie MeSH
- mozkový neurotrofický faktor * metabolismus MeSH
- neurony * metabolismus účinky léků MeSH
- protein PSD-95 metabolismus MeSH
- proteiny nervové tkáně imunologie metabolismus MeSH
- receptory N-methyl-D-aspartátu * imunologie MeSH
- synaptofysin metabolismus MeSH
- transportní proteiny MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- gephyrin MeSH Prohlížeč
- membránové proteiny MeSH
- mozkový neurotrofický faktor * MeSH
- protein PSD-95 MeSH
- proteiny nervové tkáně MeSH
- receptory N-methyl-D-aspartátu * MeSH
- synaptofysin MeSH
- transportní proteiny MeSH
Anti-N-methyl D-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune disorder characterized by IgG antibodies targeting NMDAR. The prevalence is remarkably higher in women and some develop the condition during pregnancy. While immunotherapies have shown good outcomes for pregnant mothers and their infants, the impact on early neurodevelopment remains elusive. This study investigates the effects of anti-NMDAR antibody on the development of primary cortical cultures. Anti-NMDAR antibody was administered to the cultures at day in vitro 5 for the following 5 days to assess dendritic branching and arbor complexity, and at day in vitro 14 for measuring the expression of brain-derived neurotrophic factor (BDNF) and synaptic proteins. Immature cultured neurons treated with anti-NMDAR antibody exhibited impaired dendritic branching and arbor complexity. Interestingly, BDNF expression was unaffected in mature neurons. Additionally, GluN1 expression, a mandatory NMDAR subunit, was significantly reduced, while no significant alterations were observed in PSD-95, gephyrin and synaptophysin expression. These findings shed light on the structural and synaptic impacts of anti-NMDAR antibody on immature neurons, providing evidence for their consequences in early neuronal development.
Zobrazit více v PubMed
Andrzejak E, Rabinovitch E, Kreye J, Prüss H, Rosenmund C, Ziv NE, et al. (2022). Patient-Derived Anti-NMDAR Antibody Disinhibits Cortical Neuronal Networks through Dysfunction of Inhibitory Neuron Output. J Neurosci 42(15): 3253-3270. DOI: 10.1523/JNEUROSCI.1689-21.2022. PubMed DOI
Arévalo JC, Deogracias R (2023). Mechanisms Controlling the Expression and Secretion of BDNF. Biomolecules 13(5): 789. DOI: 10.3390/biom13050789. PubMed DOI
Arshadi C, Günther U, Eddison M, Harrington KIS, Ferreira TA (2021). SNT: a unifying toolbox for quantification of neuronal anatomy. Nat Methods 18(4): 374-377. DOI: 10.1038/s41592-021-01105-7. PubMed DOI
Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, et al. (2019). An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol 18(11): 1045-1057. DOI: 10.1016/S1474-4422(19)30244-3. PubMed DOI
Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011). Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10(1): 63-74. DOI: 10.1016/S1474-4422(10)70253-2. PubMed DOI
Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. (2007). Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61(1): 25-36. DOI: 10.1002/ana.21050. PubMed DOI
Ding Y, Zhou Z, Chen J, Peng Y, Wang H, Qiu W, et al. (2021). Anti-NMDAR encephalitis induced in mice by active immunization with a peptide from the amino-terminal domain of the GluN1 subunit. J Neuroinflammation 18(1): 53. DOI: 10.1186/s12974-021-02107-0. PubMed DOI
Domise M, Sauvé F, Didier S, Caillerez R, Bégard S, Carrier S, et al. (2019). Neuronal AMP-activated protein kinase hyper-activation induces synaptic loss by an autophagy-mediated process. Cell Death Dis 10(3): 221. DOI: 10.1038/s41419-019-1464-x. PubMed DOI
García-Serra A, Radosevic M, Pupak A, Brito V, Ríos J, Aguilar E, et al. (2020). Placental transfer of NMDAR antibodies causes reversible alterations in mice. Neurol Neuroimmunol Neuroinflamm 8(1): e915. DOI: 10.1212/NXI.0000000000000915. PubMed DOI
Gleichman AJ, Spruce LA, Dalmau J, Seeholzer SH, Lynch DR (2012). Anti-NMDA Receptor Encephalitis Antibody Binding Is Dependent on Amino Acid Identity of a Small Region within the GluN1 Amino Terminal Domain. J Neurosci 32(32): 11082-11094. DOI: 10.1523/JNEUROSCI.0064-12.2012. PubMed DOI
Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, et al. (2010). Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis. J Neurosci 30(17): 5866-5875. DOI: 10.1523/JNEUROSCI.0167-10.2010. PubMed DOI
Jorratt P, Ricny J, Leibold C, Ovsepian SV (2023). Endogenous Modulators of NMDA Receptor Control Dendritic Field Expansion of Cortical Neurons. Mol Neurobiol 60(3): 1440-1452. DOI: 10.1007/s12035-022-03147-0. PubMed DOI
Joubert B, García-Serra A, Planagumà J, Martínez-Hernandez E, Kraft A, Palm F, et al. (2020). Pregnancy outcomes in anti-NMDA receptor encephalitis: Case series. Neurol Neuroimmunol Neuroinflamm 7(3): e668. DOI: 10.1212/NXI.0000000000000668. PubMed DOI
Kreye J, Wenke NK, Chayka M, Leubner J, Murugan R, Maier N, et al. (2016). Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis. Brain 139(Pt 10): 2641-2652. DOI: 10.1093/brain/aww208. PubMed DOI
Kumar MA, Jain A, Dechant VE, Saito T, Rafael T, Aizawa H, et al. (2010). Anti-N-methyl-D-aspartate Receptor Encephalitis During Pregnancy. Arch Neurol 67(7): 884-887. DOI: 10.1001/archneurol.2010.133. PubMed DOI
Li Y, Tanaka K, Wang L, Ishigaki Y, Kato N (2015). Induction of Memory Deficit in Mice with Chronic Exposure to Cerebrospinal Fluid from Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Tohoku J Exp Med 237(4): 329-338. DOI: 10.1620/tjem.237.329. PubMed DOI
Mikasova L, De Rossi P, Bouchet D, Georges F, Rogemond V, Didelot A, et al. (2012). Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain 135(Pt 5): 1606-1621. DOI: 10.1093/brain/aws092. PubMed DOI
Moscato EH, Peng X, Jain A, Parsons TD, Dalmau J, Balice-Gordon RJ (2014). Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 76(1): 108-119. DOI: 10.1002/ana.24195. PubMed DOI
Okamoto S, Takaki M, Hinotsu K, Kawai H, Sakamoto S, Okahisa Y, et al. (2022). Impairment of early neuronal maturation in anti-NMDA-receptor encephalitis. Psychopharmacology (Berl). 239(2): 525-531. DOI: 10.1007/s00213-021-06036-x. PubMed DOI
Planagumà J, Leypoldt F, Mannara F, Gutiérrez-Cuesta J, Martín-García E, Aguilar E, et al. (2015). Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. Brain 138(1): 94-109. DOI: 10.1093/brain/awu310. PubMed DOI
Taft CE, Turrigiano GG (2013). PSD-95 promotes the stabilization of young synaptic contacts. Philos Trans R Soc Lond B Biol Sci 369(1633): 20130134. DOI: 10.1098/rstb.2013.0134. PubMed DOI
Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al. (2013). Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12(2): 157-165. DOI: 10.1016/S1474-4422(12)70310-1. PubMed DOI
Würdemann T, Kersten M, Tokay T, Guli X, Kober M, Rohde M, et al. (2016). Stereotactic injection of cerebrospinal fluid from anti-NMDA receptor encephalitis into rat dentate gyrus impairs NMDA receptor function. Brain Res 1633: 10-18. DOI: 10.1016/j.brainres.2015.12.027. PubMed DOI